Develops stem cell products
Company profile
Website
CEO
Samson Tom
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
710881115
Latest filings (excl ownership)
15-12B
Securities registration termination
29 Apr 19
25-NSE
Exchange delisting
17 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Apr 19
8-K
Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc
17 Apr 19
SC TO-T/A
Third party tender offer statement (amended)
17 Apr 19
SC 14D9/A
Tender offer solicitation (amended)
17 Apr 19
Latest ownership filings
4
PETER FRIEDLI
17 Apr 19
4
Jason Keefer
17 Apr 19
4
Alla Danilkovitch
17 Apr 19
3
Samson Tom
29 Nov 18
3
Charles A. Reinhart III
17 Sep 18
3
VENTURETEC AG NEW
25 Jul 18
SC 13D/A
Osiris Therapeutics, Inc.
25 Jul 18
4
Change in insider ownership
25 Jul 18
4
Change in insider ownership
9 Jul 18
4
Jason Keefer
28 Jun 18
Institutional ownership, Q3 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|